[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

World Allergy Immunotherapy Market Assessed in Topical Daedal Research Study Available at MarketPublishers.com

02 Dec 2015 • by Natalie Aster

LONDON – Allergen immunotherapy, also terms allergy vaccine therapy, is the long-term treatment that targets the actual cause of the allergy and attempts to change the way the immune system reacts to allergens. Allergy shots decrease sensitivity to allergens, often resulting in lasting relief of allergy symptoms even after stopping the treatment.

As of 2013, there were around 400 million people across the globe suffering from allergic rhinitis and nearly 300 million from asthma, which highlights the scope of the problem. The approaches to the treatment for allergic reactions to various substances quite differ in the USA and Europe, mainly because of the differences in the availability of products.

The allergy immunotherapy market has been gaining traction, driven by such factors as increased expenditure on medicines, GDP growth, rising environmental pollution, surging prevalence of versatile allergic diseases. However, the market growth has been affected by a slew of certain challenges, with the management of allergy and the awareness of allergic problems being among the key ones. The market has also seen the growing prevalence of skin and food allergies, along with various price trends.

The competition in the worldwide allergy immunotherapy market is severe, which is led by such giants as ALK-Abello, Stallergenes, and Allergy Therapeutics.

In-demand report “Global Allergy Immunotherapy Market: Trends and Opportunities (2015-2019)” elaborated by Daedal Research provides a deep analysis of the global allergy immunotherapy market, giving insights into market sizing and growth rates, market shares and the impact of the economy on the industry. The research study examines the global allergy immunotherapy market penetration rate; provides market size of allergic rhino conjunctivitis (AR) and house dust mites (HDM) allergy disease; offers exhaustive market share analysis of the world allergy immunotherapy market by types, players and regions; offers data on the allergy immunotherapy market share in the respiratory market and prescription allergy marketplace. It also presents granular regional analysis of the allergy immunotherapy market across Europe and the USA, segmented based on type, by top players along with their pipeline products. The report evaluates the key opportunities in the market and casts light on the factors that are and are anticipated to continue to drive the sector growth. Furthermore, the research publication forecasts the growth of the overall allergy immunotherapy industry through to 2019. Detailed profiles of the leading players are available, with information of their financials and pertinent business strategies included.

Report Details:

Global Allergy Immunotherapy Market: Trends and Opportunities (2015-2019)
Published: November, 2015
Pages: 59
Price: US$ 800.00

More reports prepared by Daedal Research can be easily found in its catalogue.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected] 


Analytics & News

Weekly Digest